FLEURY (FLRY3) Main Indicators
Basic Data - FLRY3
| Company | FLEURY |
| Corporate Name | FLEURY S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | (i) prestação de serviços médicos e medicina diagnóstica; (ii) consultoria. assessoria. cursos. gestão de doenças crônicas; (iii) pesquisa e desenvolvimento; (iv) a prestação de serviços a terceiros |
| Share | FLRY3 |
| Quote Date | 11/19/2024 |
| Share Type | ON |
| Last Closing | R$ 13.85 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 32.23 M |
| Last Statement | ITR - 09/30/2024 |
| Sector | Saúde |
| Subsector | Serv.Méd.Hospit..Análises e Diagnósticos |
| Segment | Serv.Méd.Hospit..Análises e Diagnósticos |
| Participation Indexes | IBOVESPA, IBRA, IBRX, ICO2, ICON, IDIV, IGC, IGCT, IGNM, ISE, ITAG, SMLL |
| Updated 11/21/2024 | |
Relative Prices - FLRY3
| Price/Earnings | 12.35 |
| Price/SBV | 1.42 |
| Price/Net Sales | 1.00 |
| Price/CFO | 4.23 |
| Price/FCF | 5.56 |
| Price/Total Assets | 0.58 |
| Price/EBIT | 6.41 |
| Price/Working Capital | 3.57 |
| Price/NCAV | -1.36 |
| EV/EBIT | 10.77 |
| EV/EBITDA | 6.53 |
| EV/Net Sales | 1.69 |
| EV/CFO | 7.11 |
| EV/FCF | 9.34 |
| EV/Total Assets | 0.98 |
| Company Market Cap | R$ 7.58 B |
| Enterprise Value | R$ 12.74 B |
| Current Financial Statement Date | 09/30/2024 |
| Current Share Price | R$ 13.85 |
| Share Price Date | 11/19/2024 |
| Dividend Yield | 5.42% |
| Updated 11/21/2024 | |
Income Statement - FLRY3
| Net Revenue | R$ 7.55 B |
| Gross Result | R$ 2.09 B |
| EBIT | R$ 1.18 B |
| Depreciation and Amortization | - R$ 767.85 M |
| EBITDA | R$ 1.95 B |
| Net Profit | R$ 613.53 M |
| Net Profit/Share | R$ 1.12 |
| Updated 11/07/2024 | |
| Net Revenue | R$ 1.96 B |
| Gross Result | R$ 557.00 M |
| EBIT | R$ 340.12 M |
| Depreciation and Amortization | - R$ 196.61 M |
| EBITDA | R$ 536.73 M |
| Net Profit | R$ 190.71 M |
| Profit/Share | R$ 0.35 |
| Updated 11/07/2024 | |
Price and Volume Behavior - FLRY3
| Lowest Price 52 weeks | R$ 13.54 |
| Highest Price 52 weeks | R$ 17.98 |
| Variation 2024 | -19.94% |
| Variation 1 year | -15.02% |
| Variation 2 years(total) | -8.24% |
| Variation 2 years(yearly) | -4.19% |
| Variation 3 years(total) | -14.64% |
| Variation 3 years(yearly) | -5.14% |
| Variation 4 years(total) | -37.52% |
| Variation 4 years(yearly) | -11.09% |
| Variation 5 years(total) | -34.37% |
| Variation 5 years(yearly) | -8.07% |
| Average Daily Volume (3 months) | R$ 45.31 M |
| Updated 11/21/2024 | |
Returns and Margins - FLRY3
| Return on Initial Tangible Capital | 17.10% |
| Return on Initial Invested Capital | 8.45% |
| Pre-Tax Return on Initial Tangible Capital | 25.91% |
| Pre-Tax Return on Initial Invested Capital | 12.80% |
| Return on Initial Shareholder´s Equity | 11.85% |
| Return on Initial Asset | 5.32% |
| Gross Margin | 27.69% |
| Net Margin | 8.13% |
| EBIT Margin | 15.66% |
| EBITDA Margin | 25.83% |
| Initial Asset Turnover | 0.65 |
| Financial Leverage | 2.44 |
| Liabilities/Net Worth | 1.44 |
| Net Debt/EBITDA | 2.64 |
| Updated 11/07/2024 | |
Balance Sheet - FLRY3
| Cash and Cash Equivalents | R$ 12.63 M |
| Total Assets | R$ 13.03 B |
| Short-Term Debt | R$ 905.46 M |
| Long-Term Debt | R$ 4.27 B |
| Gross Debt | R$ 5.17 B |
| Net Debt | R$ 5.16 B |
| Shareholder´s Equity | R$ 5.34 B |
| Share Book Value | R$ 9.76 |
| Common Shares | 547,191,026 |
| Preferred Shares | 0 |
| Total | 547,191,026 |
| Common Shares in Treasury | 2,911,287 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 2,911,287 |
| Common Shares (Except Treasury) | 544,279,739 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 544,279,739 |
| Updated 11/07/2024 | |
Cash Flow - FLRY3
| Operating Cash Flow | R$ 1.79 B |
| Cash Flow from Investments | - R$ 1.91 B |
| Financing Cash Flow | R$ 122.08 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 1.48 M |
| Updated 11/07/2024 | |
| Operating Cash Flow | R$ 558.69 M |
| Cash Flow from Investments | - R$ 395.61 M |
| Financing Cash Flow | - R$ 160.85 M |
| Increase (Reduction) in Cash and Equivalents | R$ 2.22 M |
| Updated 11/07/2024 | |
Experimental - FLRY3
| CAPEX 3 months | - R$ 112.66 M |
| Free Cash Flow 3 months | R$ 446.03 M |
| CAPEX 12 months | - R$ 427.43 M |
| Free Cash Flow 12 months | R$ 1.36 B |
| Updated 11/07/2024 | |